Cargando…
Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson’s disease based on integrative analysis
Parkinson’s disease (PD) is one of the most prevalent movement disorders and its diagnosis relies heavily on the typical clinical manifestations in the late stages. This study aims to screen and identify biomarkers of PD for earlier intervention. We performed a differential analysis of postmortem br...
Autores principales: | Guo, Xing, Hu, Wenjun, Gao, Zijie, Fan, Yang, Wu, Qianqian, Li, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232497/ https://www.ncbi.nlm.nih.gov/pubmed/37258507 http://dx.doi.org/10.1038/s41531-023-00527-8 |
Ejemplares similares
-
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022) -
LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells
por: Kanamori-Katayama, Mutsumi, et al.
Publicado: (2011) -
Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021) -
Prognostic value and biological function of LRRN4 in colorectal cancer
por: Xu, Cheng, et al.
Publicado: (2022) -
Examination of NRCAM, LRRN3, KIAA0716, and LAMB1 as autism candidate genes
por: Hutcheson, Holli B, et al.
Publicado: (2004)